DoP circulates draft Cabinet note on drug pricing policy
Quotes

DoP circulates draft Cabinet note on drug pricing policy

Last Updated: Wednesday, October 10, 2012, 23:12
 
 Comment 1
 
DoP circulates draft Cabinet note on drug pricing policy
New Delhi: The department of pharmaceuticals (DoP) has circulated a draft Cabinet note for finalising the pharmaceutical pricing policy to fix rates of 348 essential medicines.

With the group of ministers (GoM), headed by Agriculture Minister Sharad Pawar, suggesting a market-based pricing for drugs under the National List of Essential Medicines (NLEM), DoP has taken up steps required to formalise the policy, according to official sources.

"Soon the Cabinet will take decision in this matter. A draft note has been circulated. Most of the ministries, including the Commerce and Industry, have supported the recommendations of GoM which met last month," an official said.

The group of ministers in its meeting held last month, had agreed to bring 348 medicines in the National List of Essential Medicines (NLEM) to be brought under price control.

It had mooted fixing of prices based on weighted average of prices of all brands, which have more than 1 percent market share.

Apart from Pawar, Anand Sharma and Srikant Jena, other members of the group include Health Minister Ghulam Nabi Azad, Minister for HRD, Communications and IT Kapil Sibal, Law Minister Salman Khurshid and Planning Commission Deputy Chairman Montek Singh Ahluwalia.

Earlier this month, the Supreme Court had, however, asked the government not to alter the existing manufacturing cost-based system of fixing drug prices.

PTI


First Published: Wednesday, October 10, 2012, 23:12


Comments


comments powered by Disqus
Google I/O 2014
Google I/O 2014
Maker Faire @ White House
Maker Faire @ White House
Amazon unveils 3D `Fire` smartphone
Amazon unveils 3D `Fire` smartphone
RIL`s 40th AGM
RIL`s 40th AGM
Samsung Galaxy Tab S
Samsung Galaxy Tab S

Web Wrap
Contact Us : Privacy Policy : Legal Disclaimer
Copyright © Zee Media Corporation Ltd. All rights reserved